Featured Image of Top News Story: Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19

Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19

Hospitalized adults who have COVID-19 are more than 3 times as likely to develop a blood clot than adults who do not have COVID-19, according to new research from Kaiser Permanente Southern California and Kaiser Permanente Northern California. The study published July 20 in CHEST found Black patients ...

  • Marking Clinical Trials Day 2021 with gratitude

    May 20, 2021
    On this day—May 20, 2021, aka Clinical Trials Day—we have more reasons than ever to celebrate the Kaiser Permanente Southern California clinical trials team. We began our COVID-19 clinical trials research with the remdesivir trial in March 2020. We were a top enroller in that study. Since then, our clinical trials program has participated in 9 ...
    Read more...
  • Kaiser Permanente members have higher survival rate after cancer diagnosis

    May 14, 2021
    Among insured cancer patients in Southern California, those who were diagnosed and treated at Kaiser Permanente, an integrated health care organization, had better survival rates, especially Black and Latinx patients, according to Kaiser Permanente research published in The American Journal of Managed Care. “Kaiser Permanente is committed to finding and addressing health care inequities,” said the ...
    Read more...
  • COVID-19 outcomes are more severe for people of color

    May 4, 2021
    A new Kaiser Permanente study published in Annals of Internal Medicine found that people of color were more likely to be hospitalized and to receive intensive-level care for COVID-19 compared to white patients even after adjusting for known health risk factors such as obesity, diabetes, and other conditions The study was among the first to show that these ...
    Read more...
  • Celebrating our extraordinary nurses: During Nurses Week, all month, and throughout the year

    May 4, 2021
    For National Nurses Week (May 6 to 12), Nurses Month, and Year of the Nurse, we celebrate the dedicated nurses who work in the Kaiser Permanente Southern California Department of Research & Evaluation. Nurses are a vital part of our research program. Most support clinical trials, where their relationship-building skills play an important part in helping ...
    Read more...
  • Five questions for … Dr. Ana Florea

    May 4, 2021
    Ana Florea, PhD, MPH, is an epidemiologist and post-doctoral research fellow with the Department of Research & Evaluation at Kaiser Permanente Southern California. She has special interests in vaccine safety and effectiveness, infectious diseases, cancer, and chronic kidney diseases. Currently, she is involved in projects studying shingles and Tdap vaccines. She works on projects involving ...
    Read more...
  • New Kaiser Permanente COVID-19 Vaccine Side Effect Monitoring System launches

    April 28, 2021
    A pilot program in Southern California will develop a vaccine side effect monitor that provides real-time insights to researchers and public health officials.
    Read more...
  • Child vaccination rates recovering since pandemic’s early days

    April 15, 2021
    The numbers of recommended vaccine doses, including measles vaccine, administered to children decreased dramatically after the declaration of a national state of emergency on March 13, 2020, due to the COVID-19 pandemic, according to a Kaiser Permanente study published in Pediatrics. While the decrease was lower and recovered in children under 2 years of age, ...
    Read more...
  • Most patients’ end-of-life care wishes are met

    April 6, 2021
    The vast majority of patients make their end-of-life care wishes known to loved ones, and nearly 90% of the time those wishes were carried out according to Kaiser Permanente research published April 6, 2021, in the medical journal JAMA Network Open. “There is a common perception that people don’t often document or tell others about their ...
    Read more...
  • KPSC teams with Moderna, Pfizer-BioNTech to assess real-world effectiveness of COVID-19 vaccines

    March 30, 2021
    Researchers from Kaiser Permanente Southern California are collaborating with Moderna and Pfizer-BioNTech, the makers of the 2 first authorized COVID-19 vaccines, to study their vaccines’ effectiveness in real-world settings in preventing the disease and reducing its severity. Questions these studies will evaluate range from how long protection lasts to how well vaccines perform against variants ...
    Read more...
  • New CIRT research projects aim to improve care

    March 30, 2021
    The Care Improvement Research Team has awarded funds for 7 new research projects led by Southern California Permanente Medical Group scientists and physician researchers on COVID-19 and other health topics to help improve the care physicians provide for their patients. “This kind of research provides important new evidence to our frontline clinicians,” said Nancy Gin, MD, ...
    Read more...